CZ20011518A3 - Farmaceutický prostředek - Google Patents

Farmaceutický prostředek

Info

Publication number: CZ20011518A3
Authority: CZ; Czechia
Prior art keywords: pharmaceutical preparation; pharmaceutical; preparation
Prior art date: 1998-10-30

Application number

CZ20011518A

Other languages

English (en)

Other versions

CZ297914B6 (cs

Inventor

Tahir Ahmed

Original Assignee

Baker Norton Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-30

Filing date

1999-10-13

Publication date

2002-04-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26803748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ20011518(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-13 Application filed by Baker Norton Pharmaceuticals, Inc. filed Critical Baker Norton Pharmaceuticals, Inc.

2002-04-17 Publication of CZ20011518A3 publication Critical patent/CZ20011518A3/cs

2007-04-25 Publication of CZ297914B6 publication Critical patent/CZ297914B6/cs

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Investigating Or Analysing Biological Materials (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CZ20011518A 1998-10-30 1999-10-13 Farmaceutická kompozice CZ297914B6 (cs)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10650798P	1998-10-30	1998-10-30
US09/362,540 US6235725B1 (en)	1998-10-30	1999-07-28	Methods and compositions for the prevention of tolerance to medications

Publications (2)

Publication Number	Publication Date
CZ20011518A3 true CZ20011518A3 (cs)	2002-04-17
CZ297914B6 CZ297914B6 (cs)	2007-04-25

Family

ID=26803748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ20011518A CZ297914B6 (cs)	1998-10-30	1999-10-13	Farmaceutická kompozice

Country Status (25)

Country	Link
US (1)	US6235725B1 (cs)
EP (1)	EP1124563B1 (cs)
JP (1)	JP4585121B2 (cs)
CN (2)	CN1329496A (cs)
AR (2)	AR023911A1 (cs)
AT (1)	ATE277621T1 (cs)
AU (1)	AU760119B2 (cs)
BR (1)	BR9915818A (cs)
CA (1)	CA2348926C (cs)
CO (1)	CO5160320A1 (cs)
CY (1)	CY1107493T1 (cs)
CZ (1)	CZ297914B6 (cs)
DE (1)	DE69920734T2 (cs)
ES (1)	ES2228173T3 (cs)
HK (1)	HK1041596A1 (cs)
HU (1)	HUP0302492A3 (cs)
IL (2)	IL142865A0 (cs)
IS (1)	IS2321B (cs)
NO (1)	NO333194B1 (cs)
NZ (1)	NZ511399A (cs)
PL (1)	PL195592B1 (cs)
PT (1)	PT1124563E (cs)
SK (1)	SK285150B6 (cs)
TW (1)	TW565451B (cs)
WO (1)	WO2000025723A2 (cs)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9902689D0 (en) *	1999-02-08	1999-03-31	Novartis Ag	Organic compounds
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
BR0107304A (pt) *	2000-10-12	2002-08-13	Boehringer Ingelheim Pharma	Pó para inalação contendo tiotrópio
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) *	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US20030191151A1 (en) *	2001-10-26	2003-10-09	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en)	2001-10-26	2004-03-09	Dey, L.P.	Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) *	2001-10-26	2003-07-31	Dey L.P.	Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja)	2001-10-26	2003-08-05	Dey Lp	慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030203930A1 (en) *	2001-10-26	2003-10-30	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
PT1511466E (pt) *	2002-02-18	2009-01-16	Ockham Biotech Ltd	Utilização de glicosaminoglicanos tais como heparina para o tratamento de desordens respiratórias tais como dpoc
ES2527096T3 (es) *	2002-02-18	2015-01-20	Ockham Biotech Limited	Combinación de ADNasa I y glucosaminoglucanos para su uso en limpieza de ADN extracelular
AU2003205898A1 (en) *	2002-02-18	2003-09-04	University Of Southampton	Combination therapy for respiratory disorders
SI1494732T1 (sl)	2002-03-20	2008-08-31	Mannking Corp	Inhalacijski aparat
US20040087543A1 (en) *	2002-04-25	2004-05-06	Zachary Shriver	Methods and products for mucosal delivery
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
EP1531866A1 (en) *	2002-08-29	2005-05-25	Cipla Ltd.	Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US7763280B2 (en) *	2002-11-28	2010-07-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Tiotropium containing powder formulation for inhalation
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
US20060293263A1 (en) *	2003-05-16	2006-12-28	Bbk Bio Corporation	Preparation for preventing contact of pathogenic matter with living organism
TWI359675B (en) *	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050043343A1 (en) *	2003-07-28	2005-02-24	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
KR101273120B1 (ko)	2004-08-20	2013-06-13	맨카인드 코포레이션	다이케토피페라진 합성의 촉매 작용
BR122019022692B1 (pt)	2004-08-23	2023-01-10	Mannkind Corporation	Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
KR101486829B1 (ko)	2005-09-14	2015-01-29	맨카인드 코포레이션	결정질 미립자 표면에 대한 활성제의 친화력의 증가를 기반으로 하는 약물 제제의 방법
EP1986679B1 (en)	2006-02-22	2017-10-25	MannKind Corporation	A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
TWI677355B (zh)	2008-06-13	2019-11-21	美商曼凱公司	用於藥物傳輸之乾粉吸入器及系統
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
ES2421385T3 (es)	2008-06-20	2013-09-02	Mannkind Corp	Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en)	2009-03-11	2017-03-01	MannKind Corporation	Apparatus, system and method for measuring resistance of an inhaler
MY186975A (en)	2009-06-12	2021-08-26	Mannkind Corp	Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en)	2009-11-03	2015-04-28	Mannkind Corporation	Apparatus and method for simulating inhalation efforts
US20130090371A1 (en) *	2010-04-20	2013-04-11	President And Fellows Of Harvard College	Methods and compositions for inhibition of beta2-adrenergic receptor degradation
MX359281B (es)	2010-06-21	2018-09-21	Mannkind Corp	Sistema y metodos para suministrar un farmaco en polvo seco.
US8925726B2 (en)	2011-04-01	2015-01-06	Mannkind Corporation	Blister package for pharmaceutical cartridges
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
CA2852536A1 (en)	2011-10-24	2013-05-02	Mannkind Corporation	Methods and compositions for treating pain
CA2878457C (en)	2012-07-12	2021-01-19	Mannkind Corporation	Dry powder drug delivery systems and methods
EP2911690A1 (en)	2012-10-26	2015-09-02	MannKind Corporation	Inhalable influenza vaccine compositions and methods
EP2970149B1 (en)	2013-03-15	2019-08-21	MannKind Corporation	Microcrystalline diketopiperazine compositions and methods
EP3021834A1 (en)	2013-07-18	2016-05-25	MannKind Corporation	Heat-stable dry powder pharmaceutical compositions and methods
CN105517607A (zh)	2013-08-05	2016-04-20	曼金德公司	吹入设备和方法
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
CN104069497A (zh) *	2014-06-27	2014-10-01	东莞市凯法生物医药有限公司	一种降低药物耐受性的组合物、方法及其应用
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US20190070244A1 (en) *	2017-06-30	2019-03-07	The New Zealand Institute For Plant And Food Research Limited	Boysenberry compositions and methods of preparation and use thereof
TWI811231B (zh)	2017-08-08	2023-08-11	奧德特Ｍ蕭	波森莓、蘋果及黑醋栗組成物及其製備方法與用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1195497B (it)	1983-03-08	1988-10-19	Opocrin Spa	Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
US4906476A (en)	1988-12-14	1990-03-06	Liposome Technology, Inc.	Novel liposome composition for sustained release of steroidal drugs in lungs
US5380716A (en)	1988-12-15	1995-01-10	Glycomed, Inc.	Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
US5032679A (en)	1988-12-15	1991-07-16	Glycomed, Inc.	Heparin fragments as inhibitors of smooth muscle cell proliferation
US5192548A (en)	1990-04-30	1993-03-09	Riker Laboratoires, Inc.	Device
SE9302777D0 (sv)	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
US5874063A (en)	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
US5714376A (en)	1991-10-23	1998-02-03	Massachusetts Institute Of Technology	Heparinase gene from flavobacterium heparinum
ATE128350T1 (de)	1991-12-12	1995-10-15	Glaxo Group Ltd	Pharmazeutische aerosolformulierung.
US5736124A (en)	1991-12-12	1998-04-07	Glaxo Group Limited	Aerosol formulations containing P134a and particulate medicament
CZ288032B6 (cs) *	1991-12-18	2001-04-11	Aktiebolaget Astra	Farmaceutický prostředek pro podání inhalací
US5690910A (en) *	1995-08-18	1997-11-25	Baker Norton Pharmaceuticals, Inc.	Method for treating asthma

1999
- 1999-07-28 US US09/362,540 patent/US6235725B1/en not_active Expired - Lifetime
- 1999-10-13 PT PT99971300T patent/PT1124563E/pt unknown
- 1999-10-13 ES ES99971300T patent/ES2228173T3/es not_active Expired - Lifetime
- 1999-10-13 DE DE69920734T patent/DE69920734T2/de not_active Expired - Lifetime
- 1999-10-13 EP EP99971300A patent/EP1124563B1/en not_active Expired - Lifetime
- 1999-10-13 JP JP2000579168A patent/JP4585121B2/ja not_active Expired - Fee Related
- 1999-10-13 CN CN99813923A patent/CN1329496A/zh active Pending
- 1999-10-13 CZ CZ20011518A patent/CZ297914B6/cs not_active IP Right Cessation
- 1999-10-13 SK SK590-2001A patent/SK285150B6/sk not_active IP Right Cessation
- 1999-10-13 PL PL99364727A patent/PL195592B1/pl unknown
- 1999-10-13 HK HK02103273.0A patent/HK1041596A1/zh unknown
- 1999-10-13 IL IL14286599A patent/IL142865A0/xx active IP Right Grant
- 1999-10-13 CA CA2348926A patent/CA2348926C/en not_active Expired - Fee Related
- 1999-10-13 NZ NZ511399A patent/NZ511399A/en not_active IP Right Cessation
- 1999-10-13 AU AU12051/00A patent/AU760119B2/en not_active Ceased
- 1999-10-13 HU HU0302492A patent/HUP0302492A3/hu not_active Application Discontinuation
- 1999-10-13 CN CNB2004100629128A patent/CN100352448C/zh not_active Expired - Fee Related
- 1999-10-13 WO PCT/US1999/024034 patent/WO2000025723A2/en not_active Ceased
- 1999-10-13 BR BR9915818-3A patent/BR9915818A/pt not_active Application Discontinuation
- 1999-10-13 AT AT99971300T patent/ATE277621T1/de active
- 1999-10-28 AR ARP990105443A patent/AR023911A1/es not_active Application Discontinuation
- 1999-10-29 CO CO99068642A patent/CO5160320A1/es unknown
- 1999-11-09 TW TW088118719A patent/TW565451B/zh not_active IP Right Cessation
2001
- 2001-04-27 IS IS5928A patent/IS2321B/is unknown
- 2001-04-27 NO NO20012097A patent/NO333194B1/no not_active IP Right Cessation
- 2001-04-30 IL IL142865A patent/IL142865A/en not_active IP Right Cessation
2004
- 2004-12-06 CY CY20041101437T patent/CY1107493T1/el unknown
2011
- 2011-09-07 AR ARP110103258A patent/AR082913A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK5902001A3 (en)	2002-07-02
JP4585121B2 (ja)	2010-11-24
NO20012097L (no)	2001-06-15
CA2348926C (en)	2011-08-23
AR023911A1 (es)	2002-09-04
CY1107493T1 (el)	2013-03-13
AU760119B2 (en)	2003-05-08
CN1572303A (zh)	2005-02-02
EP1124563A4 (en)	2002-01-02
PL195592B1 (pl)	2007-10-31
US6235725B1 (en)	2001-05-22
IS5928A (is)	2001-04-27
BR9915818A (pt)	2002-06-18
WO2000025723A2 (en)	2000-05-11
SK285150B6 (sk)	2006-07-07
CZ297914B6 (cs)	2007-04-25
WO2000025723A3 (en)	2000-07-27
IS2321B (is)	2007-12-15
HK1041596A1 (zh)	2002-07-12
CA2348926A1 (en)	2000-05-11
AU1205100A (en)	2000-05-22
EP1124563B1 (en)	2004-09-29
HUP0302492A2 (hu)	2003-11-28
CN100352448C (zh)	2007-12-05
DE69920734D1 (de)	2004-11-04
HUP0302492A3 (en)	2005-05-30
EP1124563A2 (en)	2001-08-22
CO5160320A1 (es)	2002-05-30
DE69920734T2 (de)	2005-10-06
NO20012097D0 (no)	2001-04-27
ATE277621T1 (de)	2004-10-15
NZ511399A (en)	2004-09-24
PT1124563E (pt)	2005-01-31
ES2228173T3 (es)	2005-04-01
PL364727A1 (en)	2004-12-13
AR082913A2 (es)	2013-01-16
NO333194B1 (no)	2013-04-02
IL142865A0 (en)	2002-03-10
TW565451B (en)	2003-12-11
IL142865A (en)	2006-07-05
JP2002535245A (ja)	2002-10-22
CN1329496A (zh)	2002-01-02

Publication	Publication Date	Title
CZ20011518A3 (cs)	2002-04-17	Farmaceutický prostředek
SG79255A1 (en)	2001-03-20	Pharmaceutical formulations
GB9817118D0 (en)	1998-10-07	Pharmaceutical compounds
CZ20011186A3 (cs)	2001-09-12	Stabilizovaný farmaceutický prostředek
GB9817623D0 (en)	1998-10-07	Pharmaceutical compounds
GB9810886D0 (en)	1998-07-22	Pharmaceutical compounds
PT1466615E (pt)	2009-09-07	Composição farmacêutica
PL343769A1 (en)	2001-09-10	Pharmaceutical composition
EP1145714A4 (en)	2004-12-15	DRUGS
PL344834A1 (en)	2001-11-19	Pharmaceutical levothyroxine preparation
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
GB9715490D0 (en)	1997-10-01	Pharmaceutical preparation
ZA982073B (en)	1998-09-16	Pharmaceutical preparation
GB9818927D0 (en)	1998-10-21	Pharmaceutical formulation
GB9823847D0 (en)	1998-12-23	Pharmaceutical compounds
GB9823845D0 (en)	1998-12-23	Pharmaceutical compounds
AU1688099A (en)	2000-07-31	Pharmaceutical preparation
GB9817470D0 (en)	1998-10-07	Pharmaceutical formulation
GB9822333D0 (en)	1998-12-09	Pharmaceutical formulation
AU2279800A (en)	2000-06-13	Pharmaceutical preparation
GB9817197D0 (en)	1998-10-07	Pharmaceutical compounds
IL126732A0 (en)	1999-08-17	Pro drug
GB9802617D0 (en)	1998-04-01	Pharmaceutical formulation
AUPP574298A0 (en)	1998-10-01	Pharmaceutical preparation
HU9800078D0 (en)	1998-04-28	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2018-05-02	MM4A	Patent lapsed due to non-payment of fee	Effective date: 20171013